San Diego, CA, United States of America

Ching-Leou Teng


 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 198(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Oligonucleotide Delivery by Ching-Leou Teng

Introduction

Ching-Leou Teng is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of pharmaceutical sciences. With a total of five patents to her name, she has focused her research on enhancing the delivery of oligonucleotides and nucleic acids through non-parenteral routes. Her work has the potential to revolutionize therapeutic applications in gene modulation.

Latest Patents

One of her latest patents is titled "Compositions and methods for non-parenteral delivery of oligonucleotides." This invention relates to compositions and methods that enhance the local and systemic uptake and delivery of oligonucleotides and nucleic acids via non-parenteral routes of administration. The pharmaceutical compositions disclosed include emulsion and microemulsion formulations for systemic delivery, as well as oral dosage formulations. Notably, it has been discovered that oligonucleotides can be locally delivered to colonic sites using rectal enemas and suppositories in simple solutions. These compositions may also include penetration enhancers to facilitate the transport of oligonucleotides across mucosal membranes. The methods are designed for oral, buccal, rectal, or vaginal administration of antisense oligonucleotides to modulate gene expression in animals for various purposes.

Career Highlights

Ching-Leou Teng has worked with notable companies in the pharmaceutical industry, including Isis Pharmaceuticals, Inc. and Pharmaessentia Corporation. Her experience in these organizations has contributed to her expertise in drug delivery systems and oligonucleotide research.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Phillip Dan Cook and Lloyd G Tillman. These partnerships have further enriched her research and development efforts in the field.

Conclusion

Ching-Leou Teng's innovative work in the delivery of oligonucleotides showcases her commitment to advancing pharmaceutical science. Her patents and collaborations highlight her significant impact on therapeutic applications in gene modulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…